Institutional Cluster

BMY

BRISTOL MYERS SQUIBB CO
BULLISH
Impact 6/10
Horizonweeks Processed1mo ago
Institutional cluster: 20 buyers, 8 sellers (bullish)
Actionable Insight ▲ Bullish

A powerful institutional cluster formed in BMY during Q2 2026, with 20 buyers accumulating $2.46B net against 8 sellers reducing by $680M. The buying is dominated by Norges Bank's massive $2.12B new position, alongside significant adds from Fidelity and T. Rowe Price, while Dodge & Cox and Capital International were notable sellers. This cluster aligns with the company's strong Q2 earnings beat and raised guidance reported 18 days prior, suggesting institutions are positioning for sustained Growth Portfolio momentum and upward earnings revisions. The absence of insider buying weakens the conviction slightly, but the scale and breadth of institutional accumulation is a strong bullish signal for the pharmaceutical giant's turnaround story.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
BMY ▼ -1.39% at T+20d
LONG call ✗ call lost -1.39% · α vs SPY +0.58% · entry $64.63 → $63.73
Next anchor: T+60d in 6w
Latest observation: T+31 -5.16% FF3 residual α
Entry anchored
Aug 14, 07:30 PM ET
via 1-min bar
T+1d
+2.20%
call +2.20% · α +2.87%
$66.05
settled 6w ago
T+5d
+4.10%
call +4.10% · α +5.29%
$67.28
settled 6w ago
T+20d
-1.39%
call -1.39% · α +0.58%
$63.73
settled 17d ago
T+60d
—
call — · α —
—
in 6w

Executive Summary

A powerful institutional cluster formed in BMY during Q2 2026, with 20 buyers accumulating $2.46B net against 8 sellers reducing by $680M. The buying is dominated by Norges Bank's massive $2.12B new position, alongside significant adds from Fidelity and T. Rowe Price, while Dodge & Cox and Capital International were notable sellers. This cluster aligns with the company's strong Q2 earnings beat and raised guidance reported 18 days prior, suggesting institutions are positioning for sustained Growth Portfolio momentum and upward earnings revisions. The absence of insider buying weakens the conviction slightly, but the scale and breadth of institutional accumulation is a strong bullish signal for the pharmaceutical giant's turnaround story.

Key Financial Metrics

Direction
accumulating
Buy Value
$3.1B
Sell Value
$680.5M
Net Flow
$2.5B

Institutional Positions

Net institutional flow: $2.5B

▲ Buyers (20)

InstitutionActionChangePosition ValueValue Δ
Norges BankNEW—$2.1B$2.1B
FidelityADD+52.7%$938.8M$291.6M
T. Rowe PriceDOUBLED+209.3%$1.8M$1.2M

▼ Sellers (8)

InstitutionActionChangePrev ValueValue Δ
Dodge & CoxNEAR_EXIT-99.1%$280.4M-$277.9M
Capital International InvestorsTRIM-29.9%$511.2M-$170.4M
Renaissance TechnologiesEXIT-100%$59.3M-$59.3M

Key Facts

  • 20 institutional buyers vs 8 sellers in Q2 2026
  • Net institutional accumulation of $2.46B
  • Norges Bank initiated a $2.12B new position (36.87M shares)
  • Fidelity added $291.6M (+52.7% position increase)
  • T. Rowe Price doubled its position (+209.3%)
  • Dodge & Cox nearly exited ($277.9M sold, -99.1%)
  • Renaissance Technologies and Bridgewater fully exited
  • Cluster follows Q2 2026 earnings beat (EPS $2.04 vs $1.60 est) and raised full-year guidance
  • No open-market insider buying during the window (institutions-only signal)

Financial Impact

Net institutional buying of $2.46B across 20 funds, with total buying value of $3.15B and total selling value of $680M

institutional ownershipfloatvaluation

Risk Factors

  • No insider buying to corroborate the institutional thesis
  • Dodge & Cox's near-exit and Capital International's trim suggest some long-term holders are skeptical
  • 13F data is 45+ days stale; positions may have been adjusted since quarter-end
  • Historical performance on BMY reports shows negative T+20 alpha, suggesting the stock has been a difficult long

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
40% bullish (35 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BMY-2026-Q2
5 reports for BMY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BMY — sortable, filterable
TypeNow
Aug 17, 2026
6w ago
Institutional Cluster
BULLISH ★ 6/10
$64.63 $63.73▼ −1.39%▲ +0.58%—
Aug 5, 2026
8w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$63.63 $67.66▲ +6.33%▲ +6.93%—
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$64.86 $66.95▲ +3.22%▼ −0.74%—
Mar 25, 2026
27w ago
DEFA14A
NEUTRAL ★ 3/10
$59.39 $58.71▼ −1.15%▼ −11.81%—
Feb 26, 2026
31w ago
Court Ruling
NEUTRAL ★ 3/10
$61.08 $59.39▼ −2.77%▲ +3.63%—
Showing 5 of 5

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 17, 2026